Avidity Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
RNA Nasdaq 2836 www.aviditybiosciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Avidity Biosciences, Inc.

Assessing Avidity Biosciences (RNA) Valuation After a 130% Year-to-Date Share Price Surge - Dec 10th, 2025 11:07 pm
Novartis Drops $1.7 Billion on AI Allergy Breakthrough - Dec 9th, 2025 6:57 am
Avidity Biosciences, Inc. (RNA): A Bull Case Theory - Dec 4th, 2025 11:59 am
Sarepta's Stock Rises on Positive Updates on DM1 Therapy - Nov 25th, 2025 11:08 am
US healthcare group Abbott bets on cancer screening technology in $23bn deal - Nov 20th, 2025 7:31 am
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44 - Nov 19th, 2025 7:13 am
Should You Rethink Avidity Biosciences After 127% Rally on Trial Breakthroughs? - Nov 14th, 2025 9:14 am
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates - Nov 10th, 2025 3:25 pm
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights - Nov 10th, 2025 2:05 pm
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Nov 4th, 2025 8:00 am
Avidity Biosciences (RNA) Soars 42% on $12-Billion Novartis Merger - Nov 2nd, 2025 11:34 pm
Exploring Avidity Biosciences (RNA) Valuation Following Recent Share Price Surge - Nov 2nd, 2025 1:10 pm
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think) - Oct 31st, 2025 7:44 am
Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for - Oct 30th, 2025 8:00 am
Novartis Lags Q3 Earnings, Announces $12B Avidity Biosciences Acquisition - Oct 28th, 2025 8:14 am
Warner Bros. Discovery upgraded, F5 downgraded: Wall Street's top analyst calls - Oct 28th, 2025 7:42 am
Avidity Biosciences (RNA) Moves 42.4% Higher: Will This Strength Last? - Oct 28th, 2025 7:17 am
Novartis Expects to Ride Out Patent Losses With Sales, Profit Growth Ahead - Oct 28th, 2025 6:30 am
S&P Futures Muted After Record Rally, FOMC Meeting and Earnings in Focus - Oct 28th, 2025 4:11 am
Dyne (DYN) Jumps 41% as Jefferies Bets Firm to Benefit from Novartis-Avidity Merger - Oct 28th, 2025 3:24 am